An upcoming webinar hosted by Avalere Health is set to discuss how states and the federal government are working to address Medicaid drug spending. The hour-long webinar is set to begin 12:30 p.m. EST on Feb. 27. Avalere Health's client solutions lead Sarah Butler will moderate the […]
Latest Stories
Study: 1 in 5 Encounter Surprise Bills for Surgery
A recent study published in JAMA suggests that 1 in 5 insured patients received a surprise bill following surgery. Researchers analyzed billing data from 347,356 surgeries. The study suggests the average out-of-network surprise bill is roughly $2,000. "In this study, we narrowed it down to […]
CTI Announces New Promotions
CTI Clinical and Consulting Services (CTI) this week announced promotions for two of its staff members, Ana Patacão and Brian Johnston. Patacão was promoted to executive director of CTI's real-world evidence and late phase department; Johnston was promoted to senior director of clinical project […]
ISPOR-FDA Summit 2020 Nears
A joint summit hosted by the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and Food and Drug Administration (FDA) Center for Devices and Radiological Health (CDRH) is set for March 31 in Silver Spring, Maryland. The ISPOR-FDA Summit 2020, which will be held at the FDA […]
ISPOR to Host Webinar on Patient-Preference Information
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is set to host a webinar March 4 on patient-preference methods and studies. The webinar is scheduled to begin noon EST March 4. ISPOR says after attending the webinar, participants will be able to: Explain the […]
More on Report from Pioneer Institute on QALY
Pharmaphorum in a recent report highlights a new analysis by the Pioneer Institute that suggests the Institute for Clinical and Economic Review's (ICER) quality-adjusted life year (QALY) methodology violates the Americans with Disabilities Act (ADA). "QALY has the potential to unlawfully […]
Optum: RWD Will Become Key Component on Pharma’s Corporate Strategy
A recent article by Optum on its Amplified blog takes a deep dive into how real-world data (RWD) will "become the bedrock that informs pharma corporate strategy." Pharmaceutical companies, the post states, must have a "data driven, long-term vision" of how diseases and treatment options might […]
Utah Flies Public Workers to Mexico for Cheaper Drugs
Utah is taking drastic steps to cut down on health costs by flying public workers to Mexico for cheaper prescription drugs, the Associated Press reports. According to the report, about 10 state workers are participating in the program, which launched about a year ago. Ann Lovell, a 62-year-old […]
Narayanan: RWD Not a Replacement for Clinical Trials
In a recent interview with the American Journal of Managed Care (AMJC), COTA Healthcare Vice President of Life Sciences Viraj Narayanan says real-world data can be used to supplement clinical trials, not replace them. "I think one of the most common myths or misconceptions we hear is that […]
Vanderbilt’s Dusetzina Talks Drug Policy
Stacie Dusetzina, Vanderbilt professor of health policy and cancer research, in a recent interview published on The Incidental Economist blog offers her take on drug policy issues. Liam Bendicksen, a Brown University undergraduate studying public health and public policy, conducted the […]
